Approval · Notice of Compliance 13270 · 2012
EXCEDE 200: Notice of Compliance 13270
Issued May 3, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13270
- Date
- May 3, 2012
- Company
- Pfizer Canada Inc., Animal Health GroupKirkland, Quebec, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indications
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EXCEDE 200 | 02360586 | Marketed |
Medicinal ingredients
- CEFTIOFUR CRYSTALLINE FREE ACID 200 MG per ML